Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arraysMustafa A. Barbhuiya(Johns Hopkins Medicine), Harsha Gowda(Yenepoya University)OncotargetJanuary 1, 201810.18632/oncotarget.24853Cited by 5SaveCiteExport RISWatch citationsRelated PapersPhosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous‐cell carcinoma|PROTEOMICS|2014|23MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma|Scientific Reports|2019|21Temporal Quantitative Proteomics Reveals Proteomic and Phosphoproteomic Alterations Associated with Adaptive Response to Hypoxia in Melanoma Cells|Cancers|2021|9